Ignite Creation Date:
2024-05-06 @ 3:56 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04803994
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2021-03-15
Brief Title:
The ABC-HCC Trial Atezolizumab Plus Bevacizumab vs Transarterial Chemoembolization TACE in Intermediate-stage HepatoCellular Carcinoma
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization Data
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Class:
OTHER
Study ID:
ABC-HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None